These drugs also have low uptake (less than 2% in the USA) due to several factors, including patients reluctance to seek treatment, lack of addiction training among healthcare providers and considerable stigma surrounding AUD and addiction. - Lorenzo Leggio, et al, Nature Medicine, December 2023 Based on the percentage of people in the United States with alcohol use disorder (11% or ~29.5 million) and the number of people who have received medication for alcohol use disorder in the past year (624,000) and the number of people taking GLP-1 drugs (7 percent of American adults or 18 million), we roughly estimate that more than 3 times as many people with AUD have been incidentally prescribed a GLP-1 in the past year than have been prescribed a medication that is FDA indicated for alcohol use disorder (~2 million vs 624,000, and these groups may overlap)
Data availability All data reported in this paper is provided in an accompanying Supporting Data Values file available for download
Current laboratory, animal, and early clinical research is encouraging and has not identified a consistent pattern of serious adverse events
Usually,the poison is in the dose, which is obviously also a factor
Nilius, B
If you are looking for semaglutide in Bloomfield Michigan, make sure to inquire regarding our weight loss program at Elysium Medical Spa in West Bloomfield Michigan